| P2093 | author name string | Alex Sigal | |
| | Alberto Gabizon | |
| | Yuval Avnir | |
| | Yechezkel Barenholz | |
| | Dina Tzemach | |
| | Keren Turjeman | |
| | Deborah Tulchinsky | |
| | Pablo Kizelsztein | |
| P2860 | cites work | Remote loading of doxorubicin into liposomes driven by a transmembrane phosphate gradient | Q80055321 |
| | Corticosteroids for the long-term treatment in multiple sclerosis | Q24242150 |
| | The in vivo delivery of heterologous proteins by microencapsulated recombinant cells | Q28139352 |
| | Mechanisms of glucocorticoid-mediated apoptosis in hematological malignancies | Q28203968 |
| | Liposomal retention of a modified anti-inflammatory steroid | Q28334832 |
| | Glatiramer acetate: evidence for a dual mechanism of action | Q33345291 |
| | Link of the mechanisms of action of glatiramer acetate to its long-term clinical data | Q33406710 |
| | Future challenges for drug delivery | Q33750617 |
| | Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids | Q34381920 |
| | Relevancy of Drug Loading to Liposomal Formulation Therapeutic Efficacy | Q35119237 |
| | Pharmacokinetics of pegylated liposomal Doxorubicin: review of animal and human studies | Q35124674 |
| | Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions | Q35745974 |
| | Liposomes in the treatment of inflammatory disorders | Q36316769 |
| | How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis | Q36520149 |
| | Interferon-beta1b in multiple sclerosis | Q36752915 |
| | Glatiramer acetate: mechanisms of action in multiple sclerosis | Q36832932 |
| | Particle shape: a new design parameter for micro- and nanoscale drug delivery carriers | Q36838213 |
| | Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect | Q37345508 |
| | Drug delivery systems. 4. Implants in drug delivery | Q37980406 |
| | Anti-tumor activity of liposomal glucocorticoids: The relevance of liposome-mediated drug delivery, intratumoral localization and systemic activity | Q39623974 |
| | Optimization of vincristine–topotecan combination — Paving the way for improved chemotherapy regimens by nanoliposomes | Q39671432 |
| | Fluidity parameters of lipid regions determined by fluorescence polarization | Q39781931 |
| | Liposomal glucocorticoids as tumor-targeted anti-angiogenic nanomedicine in B16 melanoma-bearing mice | Q39964878 |
| | Liposome drugs' loading efficiency: a working model based on loading conditions and drug's physicochemical properties | Q39972563 |
| | Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis | Q40334460 |
| | Drug targeting by long-circulating liposomal glucocorticosteroids increases therapeutic efficacy in a model of multiple sclerosis | Q40581554 |
| | Synovial accumulation of technetium labelled liposomes in rheumatoid arthritis | Q41159737 |
| | Enhancement of growth of a radiation-induced lymphoma by T cells from normal mice | Q41481549 |
| | An evaluation of transmembrane ion gradient-mediated encapsulation of topotecan within liposomes | Q41628394 |
| | Lymphocytes from SJL/J mice immunized with spinal cord respond selectively to a peptide of proteolipid protein and transfer relapsing demyelinating experimental autoimmune encephalomyelitis | Q41707193 |
| | Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance | Q43600618 |
| | A convenient and sensitive fluorescence assay for phospholipid vesicles using diphenylhexatriene | Q44239390 |
| | Complete remission of experimental arthritis by joint targeting of glucocorticoids with long-circulating liposomes | Q44504463 |
| | Liposome delivery of ciprofloxacin against intracellular Francisella tularensis infection | Q44624910 |
| | Enzymatic Assays for Quality Control and Pharmacokinetics of Liposome Formulations: Comparison with Nonenzymatic Conventional Methodologies | Q44651107 |
| | A novel liposomal bupivacaine formulation to produce ultralong-acting analgesia | Q44954332 |
| | Electrostatics of PEGylated micelles and liposomes containing charged and neutral lipopolymers | Q45307858 |
| | Supramolecular organization of S12363-liposomes prepared with two different remote loading processes | Q46187102 |
| | Effect of grafted PEG on liposome size and on compressibility and packing of lipid bilayer | Q46515132 |
| | pH determination by pyranine: medium-related artifacts and their correction | Q46804583 |
| | Amphipathic weak acid glucocorticoid prodrugs remote-loaded into sterically stabilized nanoliposomes evaluated in arthritic rats and in a Beagle dog: a novel approach to treating autoimmune arthritis | Q46830097 |
| | Early detection of liposome brain localization in rat experimental allergic encephalomyelitis | Q48220773 |
| | The antioxidant tempamine: in vitro antitumor and neuroprotective effects and optimization of liposomal encapsulation and release | Q48414903 |
| | Controlling liposomal drug release with low frequency ultrasound: mechanism and feasibility. | Q51061971 |
| | Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1). | Q54617560 |
| | High-performance liquid chromatographic determination of hydrocortisone and methylprednisolone and their hemisuccinate esters in human serum | Q66997347 |
| | Initial rate studies of hydrolysis and acyl migration in methylprednisolone 21-hemisuccinate and 17-hemisuccinate | Q67279120 |
| | Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients | Q70836772 |
| | Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery | Q71561923 |
| | Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy | Q71566289 |
| | Intralymphatic administration of liposome-encapsulated drugs to mice: possibility for suppression of the growth of tumor metastases in the lymph nodes | Q72005847 |
| | Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases | Q72927459 |
| | Stable nitroxide radicals protect lipid acyl chains from radiation damage | Q73212251 |
| | Electrostatic parameters of cationic liposomes commonly used for gene delivery as determined by 4-heptadecyl-7-hydroxycoumarin | Q73883703 |
| | A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia patients with randomization | Q74809892 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | nanotechnology | Q11468 |
| | glucocorticoid | Q422549 |
| P304 | page(s) | e25721 | |
| P577 | publication date | 2011-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids | |
| P478 | volume | 6 | |